After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.

HONG KONG, Jan. 28, 2026 /PRNewswire/ -- (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That ...

Moderna and Merck previously reported five-year follow-up data from their Phase 2b KEYNOTE-942 trial, showing that the personalized mRNA cancer therapy intismeran autogene combined with Keytruda cut ...

A case in point is the dire need for new antimicrobials, but pharmaceutical companies have little financial incentive to ...

A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...

A deep learning framework combines convolutional and bidirectional recurrent networks to improve protein function prediction from genomic sequences. By automating feature extraction and capturing long ...

Nature’s annual list of technologies to watch is a chance to celebrate progress and stimulate research into both ...

“It’s been known for a long time that obesity causes uncontrolled inflammation, but no one knew the mechanism behind it. ‌Our ...

UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly ...

AT HIS NOMINATION hearing in January 2025, Robert F. Kennedy Jr. announced he’d “do everything in my power to put the health ...

The elevation of longtime vaccine critics such as Malone and Levi to positions of influence in the ACIP is “unfortunate,” according to Robert Hopkins, M.D., an infectious disease physician and the ...

As ice and sleet from the winter storm thaw, potholes in North Texas may get worse than before. Here’s why, how to drive ...